Ocugen Appoints Dr. Mohamed Genead as Permanent Chief Medical Officer

Ocugen, Inc. has officially appointed Dr. Mohamed Genead as its Chief Medical Officer, effective June 11, 2026. This appointment makes his previous role as Acting/Interim CMO permanent. The filing also disclosed the results of its 2026 Annual Meeting of Stockholders.

Key Details

• CMO Appointment: Dr. Mohamed Genead was appointed permanent Chief Medical Officer (CMO) effective June 11, 2026. He had been serving as Acting/Interim CMO since May 8, 2026.
• Director Elections: Shareholders elected Kirsten Castillo, MBA, and Satish Chandran, Ph.D. to the Board of Directors to serve as Class III directors until the 2029 annual meeting.
• Annual Meeting Proposals: Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor and approved, on an advisory basis, executive compensation and an annual frequency for future say-on-pay votes.